WDB coco Co (TSE:7079) ROCE %: 23.18% (As of Mar. 2026)


TSE:7079 WDB coco Co Ltd TSE:7079
78 GF Score
Price 円2,529.00
GF Value 円3,452.59
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is WDB coco Co ROCE %?

WDB coco Co TSE:7079 -0.47% 78 ROCE % is 23.18% as of Mar. 2026. GuruFocus rates TSE:7079 with a GF Score™ of 78/100 and a GF Value™ of 円3,452.59 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. WDB coco Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 23.18%.

WDB coco Co  (TSE:7079) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

WDB coco Co ROCE % Related Terms

WDB coco Co ROCE % Historical Data

* Premium members only.

The historical data trend for WDB coco Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WDB coco Co ROCE % Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only 48.74 41.68 38.16 31.80 20.15

WDB coco Co Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.09 34.65 29.81 17.72 23.18
TSE:7079
78GF Score
WDB coco Co Ltd TSE:7079
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WDB coco Co ROCE % Calculation

WDB coco Co's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=964.707/( ( (5585.615 - 1079.844) + (5704.206 - 636.382) )/ 2 )
=964.707/( (4505.771+5067.824)/ 2 )
=964.707/4786.7975
=20.15 %

WDB coco Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=1121.856/( ( (5318.713 - 707.885) + (5704.206 - 636.382) )/ 2 )
=1121.856/( ( 4610.828 + 5067.824 )/ 2 )
=1121.856/4839.326
=23.18 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 23.18% mean?
WDB coco Co (TSE:7079) has a ROCE % of 23.18% as of Mar. 2026.
Is WDB coco Co's ROCE % too high?
WDB coco Co's current ROCE % is 23.18%. The Healthcare Providers & Services industry median ROCE % is 6.43. WDB coco Co's value of 23.18% is 260.5% above this industry median. Overall, WDB coco Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does WDB coco Co's ROCE % compare to VEEV and BTSG?
WDB coco Co's ROCE % of 23.18% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.43. WDB coco Co's value of 23.18% is 260.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.43, based on 645 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. WDB coco Co's current ROCE % of 23.18% is 260.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WDB coco Co's current ROCE % is 23.18%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WDB coco Co stock overvalued right now?
Based on GuruFocus' analysis, WDB coco Co (TSE:7079) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,452.59, compared to a current price of 円2,529.00 — trading 26.8% below its estimated fair value. The current ROCE % is 23.18% and 260.5% above the Healthcare Providers & Services industry median of 6.43. WDB coco Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For WDB coco Co (TSE:7079), the current ROCE % is 23.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is WDB coco Co (TSE:7079) Overvalued in 2026?

Based on GuruFocus' analysis, WDB coco Co stock appears to be undervalued. The current stock price of 円2,529.00 is trading 26.8% below its estimated GF Value™ of 円3,452.59. GuruFocus considers WDB coco Co to be Modestly Undervalued.

Key valuation signals for TSE:7079:

  • ROCE %: 23.18%
  • GF Value™: 円3,452.59 vs. price of 円2,529.00 (26.8% below fair value)
  • GF Score™: 78/100 with 3 warning signs
  • Industry Position: 260.5% above the Healthcare Providers & Services median

No single metric tells the full story. See the TSE:7079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

WDB coco Co Business Description

Address 1-8-11 Harumi, Chuo-ku, Triton Square Y Building, 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC-related work, PMS facility contract support related work, clinical research support/monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments, such as monitoring, safety information, data management, and statistical analysis. It provides support for the development of generic drugs, such as bioequivalence studies and biosimilars, clinical research, and physician-led clinical trials.
78GF Score

Get the complete analysis for TSE:7079

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,529.00
Price
円3,452.59
GF Value